Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. (SPLENDOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00770835
Recruitment Status : Completed
First Posted : October 10, 2008
Last Update Posted : July 12, 2011
Sponsor:
Information provided by:
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2011
  Actual Study Completion Date : May 2011